Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PREP | P48147 | 15/20 | 0.67 |
| ▸ | FAP | Q12884 | 14/20 | 0.67 |
| ▸ | DPP8 | Q6V1X1 | 6/20 | 0.66 |
| ▸ | DPP9 | Q86TI2 | 5/20 | 0.66 |
| ▸ | DPP4 | P27487 | 9/20 | 0.46 |
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.46 |
| ▸ | PITRM1 | Q5JRX3 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29162847 | 1.00 | PREP (0.67) | PREPFAPDPP8DPP9DPP4 | |
| SCHEMBL23876857 | 1.00 | PREP (0.67) | PREPFAPDPP8DPP9DPP4 | |
| SCHEMBL25890297 | 0.85 | PREP (0.77) | PREPFAPDPP8DPP9DPP4 | |
| SCHEMBL25896315 | 0.85 | FAP (0.61) | PREPFAPDPP8DPP9DPP4 | |
| SCHEMBL25890341 | 0.82 | PREP (0.79) | PREPFAPDPP8DPP9DPP4 | |
| SCHEMBL29162866 | 0.81 | FAP (0.49) | PREPFAPDPP8DPP9DPP4 | |
| SCHEMBL30805672 | 0.81 | FAP (0.49) | PREPFAPDPP8DPP9DPP4 | |
| SCHEMBL25895634 | 0.81 | PREP (0.56) | PREPFAPDPP8DPP9DPP4 | |
| SCHEMBL29359250 | 0.80 | PREP (1.00) | PREPFAPDPP8DPP9DPP4 | |
| SCHEMBL25890370 | 0.79 | FAP (0.74) | PREPFAPDPP8DPP9DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4331624-A4 | RADIOPHARMACEUTICALS BASED ON ((R)-1-((6-HYDRAZINYLNICOTINOYL)-D-ALANYL)PYRROLIDIN-2-YL)BORONIC ACID (HYNIC-IFAP) FOR DETECTING THE OVEREXPRESSION OF FIBROBLAST ACTIVATION PROTEIN | INSTITUTO NAC DE INVESTIGACIONES NUCLEARES (MX) | 2026-05-06 | — | — | EP | disclosed |
| US-20240216551-A1 | RADIOPHARMACEUTICALS BASED ON ((R)-1-((6-HYDRAZINYLNICOTINOYL)-D-ALANYL)PYRROLIDIN-2-YL)BORONIC ACID (HYNIC-IFAP) FOR DETECTING THE OVEREXPRESSION OF FIBROBLAST ACTIVATION PROTEIN | INSTITUTO NACIONAL DE INVESTIGACIONES NUCLEARES (MX) | 2024-07-04 | — | — | US | disclosed |
| EP-4331624-A1 | RADIOPHARMACEUTICALS BASED ON ((R)-1-((6-HYDRAZINYLNICOTINOYL)-D-ALANYL)PYRROLIDIN-2-YL)BORONIC ACID (HYNIC-IFAP) FOR DETECTING THE OVEREXPRESSION OF FIBROBLAST ACTIVATION PROTEIN | Instituto Nacional de Investigaciones Nucleares (MX) | 2024-03-06 | — | — | EP | disclosed |
| CN-117642188-A | Radiopharmaceuticals based on ((R) -1- ((6-hydrazinonicotinyl) -D-alanyl) pyrrolidin-2-yl) boronic acid (HYNIC-IFAP) for detection of fibroblast activation protein overexpression | 国家核研究所 | 2024-03-01 | — | — | CN | disclosed |
| WO-2022231410-A1 | RADIOPHARMACEUTICALS BASED ON ((R)-1-((6-HYDRAZINYLNICOTINOYL)-D-ALANYL)PYRROLIDIN-2-YL)BORONIC ACID (HYNIC-IFAP) FOR DETECTING THE OVEREXPRESSION OF FIBROBLAST ACTIVATION PROTEIN | INSTITUTO NACIONAL DE INVESTIGACIONES NUCLEARES (MX) | 2022-11-03 | — | — | WO | disclosed |
| WO-2022231410-A1 | RADIOPHARMACEUTICALS BASED ON ((R)-1-((6-HYDRAZINYLNICOTINOYL)-D-ALANYL)PYRROLIDIN-2-YL)BORONIC ACID (HYNIC-IFAP) FOR DETECTING THE OVEREXPRESSION OF FIBROBLAST ACTIVATION PROTEIN | INSTITUTO NACIONAL DE INVESTIGACIONES NUCLEARES (MX) | 2022-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240216551-A1 | RADIOPHARMACEUTICALS BASED ON ((R)-1-((6-HYDRAZINYLNICOTINOYL)-D-ALANYL)PYRROLIDIN-2-YL)BORONIC ACID (HYNIC-IFAP) FOR DETECTING THE OVEREXPRESSION OF FIBROBLAST ACTIVATION PROTEIN | FAP, FIBP, ENPEP | PREP 88/4885FAP 1/4885DPP8 766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.